|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/00 |
| (11) | Patento numeris | 2521776 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11731733.9 |
| Europos patento paraiškos padavimo data | 2011-01-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-11-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-11-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IL2011/000007 |
| Data | 2011-01-05 |
| (87) | Numeris | WO 2011/083464 |
| Data | 2011-07-14 |
| (30) | Numeris | Data | Šalis |
| 282247 P | 2010-01-07 | US | |
| 282228 P | 2010-01-05 | US |
| (72) |
COHEN, Yael, IL
SHER, Naamit, IL
FEIGE, Erez, IL
BANGIO, Livnat, IL
BREITBART, Eyal, IL
|
| (73) |
Vascular Biogenics Ltd.,
6 Jonathan Netanyahu Street, 60376 Or Yehuda,
IL
|
| (54) | METHODS FOR USE OF A SPECIFIC ANTI-ANGIOGENIC ADENOVIRAL AGENT |
| METHODS FOR USE OF A SPECIFIC ANTI-ANGIOGENIC ADENOVIRAL AGENT |